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KOMPOSIT KALSIUM FOSFAT- NANO TIUB KARBON BERBILANG 
SEBAGAI PENGGANTI TULANG MELALUI PENYUNTIKAN 
 
ABSTRAK 
Semen kalsium fosfat (CPCs) telah menunjukkan prestasi yang sangat baik sebagai 
bahan pengganti tulang tanpa kesan sampingan dalam kedua-dua in vitro dan in vivo. 
Namun, kelemahan CPCs mengakibatkan ia mengalami kekuatan mampatan yang 
rendah dan membataskan kebolehgunaannya dalam ortopedik. Oleh sebab itu, tujuan 
projek ini adalah untuk menghasilkan bahan pengganti tulang yang boleh suntik dan 
CPCs yang mengandungi pelbagai jenis nano tiub karbon berbilang (MWCNTs) dan 
“bovine serum albumin” (BSA) bagi membentukkan CPC/MWCNTs/BSA komposit 
dengan tujuan memperbaiki kekuatan mampatan bagi CPCs tulen. Kehadiran 
MWCNTs dan BSA mempunyai kesan yang signifikan dalam mempengaruhi 
morfologi hidroksiapatit (HA) kristal dalam matriks CPCs. BSA bertindak sebagai 
mangkin pertumbuhan HA pada permukaan CPCs. Dengan demikian, penambahan 
MWCNTs dan BSA menyebabkan peningkatan kekuatan mampatan dengan 
mengubahsuaikan ciri-ciri kristalit untuk komposit. Bagi proses pembelajaran yang 
sistematik, rekabentuk eksperimen (DOE) digabungkan dengan metodologi 
permukaan sambutan (RSM) dan rekabentuk ujikaji gabungan pusat (CCD) telah 
digunakan untuk mengkaji hubungkait antara kekuatan mampatan bagi komposit 
dengan parameter yang dikaji. Matlumat ini seterusnya digunakan untuk tujuan 
pengoptimuman kekuatan mampatan. Ujian kekuatan mampatan, pengimbasan 
mikroskop elektron (SEM), spektroskopi inframerah transformasi Fourier (FTIR) dan 
ujian kebolehsuntikan dijalankan untuk menilai sifat-sifat bagi komposit. Keputusan 
kajian menunjukkan bahawa CPCs komposit yang mengandungi MWCNT-OH dan 
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BSA menunjukkan kekuatan mampatan yang tertinggi (60 MPa) selepas 28 hari 
perendaman dalam simulasi bendalir tubuh (SBF). 
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CALCIUM PHOSPHATE-MULTIWALLED CARBON NANOTUBES 
COMPOSITES FOR INJECTABLE BONE SUBSTITUTE 
 
ABSTRACT 
Calcium phosphate cements (CPCs) has shown very good performance as bone 
substitute material without any side effects for both in vitro and in vivo. However, 
these CPCs suffer from a relatively low compressive strength, limiting its 
applicability in orthopedics. Therefore, the aim of this project is to develop the 
injectable bone substitute (IBS) consisting of CPCs with different types of 
multiwalled carbon nanotubes (MWCNTs) and bovine serum albumin (BSA) to 
create CPC/MWCNTs/BSA composites with the purpose of improving the 
mechanical properties of the pure CPCs. The presence of MWCNTs and BSA were 
found to have significant effects in influencing the morphology of hydroxyapatite 
(HA) crystals in CPCs matrix. BSA was found to act as promoter for HA growth 
when bounded to the surface of CPCs grains. Thus, the addition of MWCNTs and 
BSA could lead to an improvement of compressive strength by modifying the 
properties of the crystallites. In order to have a systematic process study, design of 
experiment (DOE) coupled with response surface methodology (RSM) and central 
composite design (CCD) was used to investigate the relationship between the 
compressive strength of the composites with the process parameters studied, which 
was then used for the optimization process. Compressive strength tests, scanning 
electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR) and 
injectability tests were used to evaluate the composites properties. Characterization 
results showed that CPCs composites containing hydroxyl group functionalized 
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MWCNT (MWCNT-OH) and BSA exhibited the highest compressive strength (60 
MPa) after 28 days immersion in simulated body fluid (SBF). 
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CHAPTER ONE: 
INTRODUCTION 
 
This chapter provides detail introduction of this research project. Brief 
definition, current medical problems and benefits of using injectable bone substitute 
(IBS) are included in this chapter. It concludes with the problem statement, scope of 
study, objectives and thesis organization of this research project. 
 
1.1 Why Injectable Bone Substitute (IBS)? 
Calcium phosphate (CaP) ceramics are the main raw materials used in blocks 
or granules for bone substitutes (Suchanek and Yoshira, 1998). These forms are 
limited value when cavities are not easily accessible or when it would be preferable 
to perform micro-invasive percutaneous surgery. Contradict to the general practice in 
visceral surgery, percutaneous surgery is less frequently than open surgery in 
orthopedics. In the present time, improvements in specific instrumentation and the 
use of bioresorbable polymer implants for bone fracture healing have contributed to 
the development of this minimal invasive technique. Thus, there is a need to develop 
IBS (Weiss et al., 1999; Daculsi et al., 1999). IBS requires suitable properties to 
ensure bonding of the mineral phase in situ with good cell permeability. Contradict 
to the use of dense materials which do not have any inherent porosity, this approach 
provides rapid improvement in deep bone formation. IBS could be produced in a 
sterile stage ready to use. Its stable composition and mechanical properties are 
suitable for the reproducibility of the biological response. A list of desirable 
properties for an ideal IBS, as identified by different workers (Heini and Berleman, 
2001; Phillips, 2003) is presented in Table 1.1.  The most important properties are 
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easy injectability, high radiopacity, dough viscosity that does not change much 
between mixing and delivery into the vertebral body, a resorption rate that is neither 
too fast nor too slow and mechanical properties that are comparable to those of a 
healthy intact vertebral body (Heini and Berleman, 2001). 
 
Table 1.1: Desirable properties of an ideal IBS (Heini and Berlemann, 2001; Phillips, 
2003). 
 
 Very high radiopacity 
 Ease of preparation and handling 
 Very easy injectability into the 
collapsed vertebral body 
 No toxicity 
 Low cost 
 Low curing temperature 
 Working time of about 6-10 min 
 Setting time of about 15 min 
 Resorption rate that is neither too 
high nor too low 
 Excellent osteoconductivity 
 Excellent osteoinductivity 
 Excellent biocompatibility   
 Excellent bioactivity  
 Adequate mechanical properties that would allow for immediate reinforcement of 
the vertebral body and ensure early ambulation of the patient; for example, values 
of modulus of elasticity and strength should be comparable to those of a healthy 
vertebral body 
 Appropriate cohesion; that is, dough sets in a fluid without disintegration (this is 
achieved by keeping a high viscosity for the dough) 
 A curing dough whose initial viscosity is low (but not low enough to have the 
potential for extravasation) and a change in that viscosity that is practically 
invariant with setting time 
 Microporosity (mean pore diameter < 10 µm), to allow circulation of body fluid 
 Macroporosity (mean pore diameter >100 µm), to provide a scaffold for blood-
cell colonization 
 
Furthermore, there has been considerable work on the development of IBS 
materials to improve the currently surgical implant method (Grimandi et al., 1998; 
Knaack et al., 1998; Gauthier et al., 1999; Tamada et al., 1999). IBS formulations 
are attractive since they can be used for the purpose of minimally invasive surgical 
procedures and can be molded to exactly fill irregular bone defects (Peter et al., 
1998). Grimandi et al. (1998) and Gauthier et al. (1999) worked on an IBS composed 
of a methylhydroxypropylcellulose (MHPC) matrix incorporating bicalcium 
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phosphate (BCP) granules. Both groups found that the IBS provides an excellent 
bioactive matrix for bone ingrowth promoting cell colonization, but the material is 
lacked suitable mechanical properties. The latter group also distinguished that 
smaller BCP granules obtained greater inflammatory response, with macrophages 
being recruited to the implant site. This in turn tended to increase the degradation 
rate of the bone substitute, apparently through signaling and recruitment of other 
bone remodeling cells (Daculsi et al., 1995; Grimandi et al., 1998; Gauthier et al., 
1999). To improve the mechanical properties of an IBS and to stabilize it at the 
implant site, many researchers investigated alternatives to IBS formulations that set 
in situ, primarily through cross linking reactions. Polyalkenoate cements, used as 
dental cements and fillers, consist of a basic metal oxide like zinc oxide and a 
polyacid, such as poly(acrylic acid) (PAA). The acid reacts with the base to form a 
cross linked metal-polyacrylate salt. In order to improve the bioactivity of these 
cements, Kenny et al. (2000) mixed apatite into the formulations and varied the 
molecular weight of the polyacid. They obtained cements that set at body 
temperature, with the potential to chemically bond to bone, exhibit no shrinkage and 
possess mechanical properties comparable to acrylic cements. The mechanical 
performance of these systems improved with increasing polyacid molecular weight. 
Watson et al. (1999) reacted tetracalcium phosphate (TTCP) with PAA, forming a 
cross linked hydroxyapatite (HA)-calcium polyacrylate composite. In aqueous 
solution, TTCP hydrolyzes to HA and the calcium cation neutralize the PAA, 
forming the cross linked network. The reaction between TTCP and PAA was very 
fast and controlled by prehydration of the TTCP to form a slower reacting HA 
surface layer. In contrast, Reed et al. (1996) synthesized a dicarboxy 
polyphosphazene that can be cross linked by di- or trivalent cation. The cations are 
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calcium ions from TTCP and dicalcium phosphate dehydrate (DCPD). They obtained 
cements with a compressive strength of the order of 10 MPa and 65 % porosity. 
Mimicking the setting of polymethylmethacrylate (PMMA) cements, Peter et al. 
(1999) used a vinyl monomer to crosslink poly(propylene-co-fumarate) (PPF). They 
were able to make quick setting, degradable cements, with low heat output and 
compressive strengths in the range of 1-12 MPa by varying the PPF molecular 
weight, as well as monomer, initiator and porogens content like sodium chloride 
(NaCl). Li et al. (2000) prepared an acrylic cement with a strontium-containing HA 
(Sr-HA) that cured at temperatures lower than PMMA-based cements, but with 
comparable mechanical properties, with the intention that the Sr-HA would improve 
the ability to bond the bone. Finally, a novel IBS was described by Turczyn et al. 
(2000), where a silanized hydroxyethylcellulose carrier was mixed with BCP. The 
suspension was in liquid form at pH 10-12, but gels quickly at pH < 9.  
 
Self-setting calcium phosphate cements (CPCs) have been first expanded and 
many of them are commercially available (Frankenburg et al., 1998; Larsson and 
Bauer, 2002; Cassidy et al., 2003). IBS are being developed based on the suspension 
of CaP granules in a carrier phase consisting of polymeric water solution of non-
ionic cellulose ether especially for the application in invasive surgery and drug 
delivery system. The resulting composite provides a ready to use, sterile, injectable 
material (Daculsi et al., 1995; Grimandi et al., 1998). Such IBS have shown ability to 
support more extensive and early bone substitution than macroporous implants or 
CaP bone cement but have not been yet studied for biomechanical competence after 
implantation (Gauthier et al., 1999; Gauthier et al., 2003). 
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Two different types of IBS compounds have been developed for example 
CPCs that harden in situ and exhibit interesting mechanical properties and IBS 
associating with polymer and CaP mineral phase, which possess osteoconduction 
qualities similar to those of macroporous ceramics (Iijima, 1991; Munting et al., 
1993; Miyamoto et al., 1997; Bo et al., 1999; Grimandi et al., 1998; Gauthier, Boix 
et al., 1999). New injectable biomaterials consisting of bioactive CaP ceramics fillers 
and hydrophilic polymer matrix were studied by Weiss et al. (1999) for bone and 
dental surgery. 
 
In summary, IBS represent an ideal material for many bone repair 
applications provided that the osteoconductive properties and ease of use can be 
associated with adequate mechanical properties. It is also clear that any effort to 
develop IBS should include a fundamental examination of all items listed in Table 
1.2 (Kenny and Buggy, 2003). Furthermore, IBS materials should exhibit good 
workability, have a suitable set time with low heat output, good mechanical 
properties, non-toxic, biocompatible, osteoconductive and they should integrate with 
bone over the time scale of bone ingrowth and remodeling (Rafal, 2001). 
 
Table 1.2: List of criteria for the design of new IBS materials (Kenny and Buggy, 
2003). 
 
Criterion Purpose 
Mechanical properties to match 
those of bone 
Enhance the elimination of the phenomenon 
known as stress shielding  
Quick setting (5-15 minutes) To assists in clinical use and after care of patient 
In situ setting at body 
temperature 
Elimination of necrosis of the adjacent tissue 
Bonding to bone and medical 
grade alloys 
Elimination of fibrous capsule and thus loosening 
of the implant 
Bioactive bone in-growth Enhancing both stress transfer and chemical 
attachment of the implant 
Radio opaque Subsequent monitoring of implant 
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The advantages of injectable CPC include easy placement in surgery, able to 
be used in difficult surgical sites that are not freely accessible by open surgery, 
capable of filling narrow defects and facilitating minimally invasive techniques. 
Furthermore, to improve the mechanical properties of CPCs, many researchers have 
blended polymers, organic or inorganic additives, bioglass and carbon nanotubes 
(CNTs) with the cements (Low et al., 2010).  
 
1.2 Problem Statement 
Due to increasing of population ageing, osteoporosis is becoming 
progressively a more common medical problem leading to higher rate of bone 
fractures (Bohner et al., 2003).  For example vertebral fractures, may cause persistent, 
often excruciating pain, which impairs mobility and reduces the patient’s quality of 
life. Management of vertebral bone fractures includes analgesics, bed rest and 
external bracing. Even with these types of treatment, progressive kyphosis, 
prolonged pain and disability still may occur. A major clinical problem with a high 
risk of severe kyphosis can develop such as multiple contiguous compression 
fractures in the thoracic and thoracolumbar spine. Therefore, there is a need for 
treatment that could decrease the occurrence of these fractures and improve 
management options once these fractures occur. It has been demonstrated that using 
minimally invasive bone cement injection for stabilizing osteoporosis or treating 
vertebral bone fracture has significant clinical benefits. At present, there is an 
increase in the usage of cement augmentation techniques such as vertebroplasty and 
kyphoplasty for treating persistent painful vertebral compression fractures (Bo et al., 
1999). One extensive category of potential intervention involves the fortification or 
augmentation of the vertebral bones. In addition to prophylactically stabilizing 
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osteoporotic bones at risk for fracture, augmentation of vertebral bones that already 
have fractured may prove useful by reducing pain, improving function and 
preventing further collapse and deformation (Bostrom et al., 1997). 
 
Therefore, there are several limitations and problems faced for IBS. Hence, 
this research is carried out focusing on the development of CPC composites and it 
application as IBS. The study will also focus on how to improve the CPC mechanical 
properties by using multiwalled CNTs (MWCNTs) and overcome their drawback 
which limits its clinical use such as, low mechanical strength and poor injectability. 
Besides, the bovine serum albumin (BSA) was also incorporated in the CPC 
composites in order to improve the mechanical properties by promoting the HA 
crystal growth.  
 
1.3 Scope of Study 
CPCs are bone substitute material which has shown very good performance 
without outside effects, both in vitro and in vivo (Knaack et al., 1998; Lee et al., 
1999). However, the final cement suffers from a relatively low compressive strength, 
limiting its applicability in orthopedics. The aim of this project is to develop IBS 
consisting of CPC with different types and weight percent (wt %) of MWCNTs and 
different wt % of BSA to create CPC/MWCNTs/BSA composites with the purpose 
of improving the mechanical properties of the CPC. Drawing on the results from the 
literature, MWCNTs have been chosen as a result of their impressive list of 
superlatives including mechanical strength, stiffness and their applications in 
biological and biomedical systems. BSA acts as promoters of CaP crystal growth 
when bound to a surface and hence has also included in this study. Thus, the addition 
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of MWCNTs and BSA could lead to an improvement of mechanical properties by 
modifying the properties of the crystallites, thereby possibly resulting in a composite 
of higher density and improved mechanical properties. The composites formulated 
will be expected to exhibit compressive strengths higher than the pure IBS material. 
In each case, characterization techniques will be considered to evaluate the final 
product properties. Moreover, the interfacial bonding between the phases, CPC, 
MWCNTs and BSA which is an important consideration for composite materials will 
also considered. Finally, the biocompatibility of selected samples will be carried out 
by in-vitro for biological evaluation.  
 
 The compressive strength of the CPC/MWCNTs/BSA composites will also 
be studied and performed using design of experiment (DOE) occupying response 
surface methodology (RSM) coupled with central composite design (CCD) with the 
assistant of Design Expert 6.0.6 software.  
 
1.4 Objectives 
The aim of this project is: 
i. To develop IBS consisting of CPC with different types of MWCNTs (e.g. as-
pristine MWCNT (MWCNT-AP), hydroxyl group functionalized MWCNT 
(MWCNT-OH) and carboxyl group functionalized MWCNT (MWCNT-
COOH)), different wt % of respective MWCNTs and BSA to create 
CPC/MWCNTs/BSA composites with the purpose of improving the 
compressive strength and injectability of the CPC. 
ii. To optimize the compressive strength of the CPC/MWCNTs/BSA composites 
produced using RSM couple with CCD. 
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iii. To study the in vitro biological test on the optimum CPC/MWCNTs/BSA 
composites. 
 
1.5 Organization of The Thesis 
This thesis consists of five chapters. Chapter one provides an outline of the 
overall research project including introduction on IBS. Problem statement was 
written after reviewing the current scenario of the CPC. The problem statement 
reveals the problems faced by the surgical implant and the importance of this 
research project. The original objectives of this research project were then carefully 
formulated with the intention to address the problems encountered by the bone 
fracture patients. Lastly, the organization of the thesis highlights the content of each 
chapter.  
 
Chapter two gives an overall review of various research works reported in the 
literature in this area of study which includes properties of CPC, MWCNTs and BSA, 
also the current status of using MWCNTs in the CPC and its application are reported 
in the review.  
 
Experimental materials and methodology were discussed in chapter three. 
This chapter describes details information on the overall flow of this research works 
and some experimental methods in conducting this research project. In addition, 
material, chemicals and equipments used in this study were also reported. This 
chapter also includes the information required for the calculation of injectability and 
compressive strength. The characterization process and data analysis also will be 
including in this chapter. 
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Chapter four perhaps is the heart of the thesis since it includes detail 
discussion on the results obtained in the present research work. This chapter consists 
of four sections which have been divided according to the stages of this research 
work. First section described the formation of CPC/MWCNTs/BSA composites in 
details. Section two of this chapter presents the investigated the effect of different 
types of MWCNTs, different wt % of MWCNTs and BSA in the compressive 
strength of the CPC composites by using the DOE approach before further 
experimental works were carried out. At the end of this section, characterization of 
CPC/MWCNTs/BSA composites produced under optimum conditions was reported. 
This section also reports the characterization result of CPC/MWCNTs/BSA 
composites for the effect of using different types of MWCNTs. Process study on the 
compressive strength of CPC/MWCNTs/BSA composites was being discussed in this 
section. Section three will discuss on the in vitro biological evaluation result for the 
CPC/MWCNTs/BSA composites. 
 
Chapter five, the last chapter of this thesis, provides a summary on the results 
obtained in this research project. This chapter concludes the overall research project 
and gives some recommendations for future studies related to this research works.     
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CHAPTER TWO: 
LITERATURE REVIEW 
 
2.1       Bone Substitute Material: Calcium Phosphate Cements (CPCs) 
2.1.1    Properties of Calcium Phosphate Cements (CPCs) 
The possibility to obtain monolithic calcium orthophosphate ceramics at 
ambient or body temperature via a cementation reaction was put forward by LeGeros 
et al. (1982) and Brown and Chow (Brown and Chow, 1983; Brown and Chow, 1985; 
Brown and Chow, 1986) in the early 1980s. Currently, this type of material is known 
as CPC and due to their suitability for repair, augmentation and regeneration of 
bones, they might be named as calcium phosphate bone cements (CPBC) (Driessens 
et al., 1995). CPC is a synthetic bone graft material that was invented in 1986 by 
Brown and Chow, scientists at the American Dental Association (Brown and Chow, 
1985). The cement is a white powder consisting of equimolar amounts of 
tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA) or 
dicalcium phosphate dehydrate (DCPD) or β-tricalcium phosphate (β-TCP), which 
are mixed with water in a liquid-to-powder (L/P) ratio of 1:4 to form a paste that can 
be conventional to osseous defects with complex shapes and set in vivo to form HA 
with excellent osteoconductivity without any acidic or basic byproduct (Brown and 
Chow, 1985; Bo et al., 1999). CaP is used by our body to build bone tissue and is 
being applied to produce biomaterials for bone repair. The CaP biomaterials are 
discussed in relation to bone repair because CaP, in particular carbonated HA (Bo et 
al., 1999) is the major inorganic component of bone. The CPCs are hydraulic 
cements. This setting is attained by an acid-base or hydrolysis reaction between a 
powder and liquid. After mixing, a CaP of intermediate alkalinity precipitates. A 
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cement material consists of solid powder phase which initially forms a plastic paste 
by mixing with liquid phase which can be shaped during surgery to fit the contours 
of a wound. This viscous paste will convert into a stiff paste during setting, 
increasing its mechanical strength up to saturation or hardening. CPCs generally 
consist of an aqueous solution and powder that typically contains several CaP 
compounds. Upon mixing, the powder dissolves in the aqueous solution and new 
forms of crystals precipitate, the reaction proceeds until all reactive CaP compounds 
react. Cement hardening occurs with the entanglement of CaP crystals, hence leading 
to a highly porous structure. The final product has porosity close to 40 to 60 %, with 
pores ranging typically from 0.1 to 10 μm. It is important to note that CPCs are 
mechanically much stronger in compression than in tension or shear, because 
entangled crystals are not well bonded. Compressive strength values are typically 5 
to 10 times larger than the tensile strength (Bohner and Baroud, 2008).  
 
Two categories of CaP exist including apatite CPC and brushite CPC. The 
main difference between apatite and brushite CPCs lies in their solubility and hence 
resorption rate with brushite being much more soluble than apatite, so brushite CPCs 
in principle resorb faster than apatite CPCs (Bohner, 2000). For the majority of 
apatite cements, water is not a reactant in the setting reaction. Therefore, the quantity 
of water actually needed for setting of apatite cements is very small (Lacout et al., 
1996; Weiss et al., 2003). However, for brushite cements, water always participates 
in the chemical transformations because it is necessary for DCPD formation. Due to 
this reason, brushite cements are always hydraulic, while usually this term is not 
associated with apatite cements (Sergey, 2008). In contrast to apatite cements, 
brushite cements can be initially liquid and still set within a short period of time 
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(Bohner, 2000; Bohner, 2001). Brushite cements are remarkable biocompatible and 
bioresorbable. Due to both a better solubility of DCPD if compared to that of 
calcium-deficient hydroxyapatite (CDHA) and metastability of DCPD under 
physiological conditions (Vereecke and Lemaître, 1990), brushite cements are faster 
degradable than apatite cements (Klein et al., 1985; Apelt et al., 2004). They are 
quickly resorbed in vivo and suffered from a rapid decrease in strength (although the 
mechanical properties of the healing bone increase as bone ingrowth occurs (Ikenaga 
et al., 1998)). However, short setting times, low mechanical strength and limited 
injectability prevent brushite cements from a broader clinical application (Sergey, 
2008). In addition, brushite cements has such a fast setting reaction (several times 
faster than apatite cements), that high liquid to powder (L/P) ratios have to be used 
for brushite cements to keep the cement paste workable or injectable over an 
adequate time.  The increase in liquid content resulted in a highly porous thus 
weaken the material (Barraleta et al., 2004). 
 
Furthermore, synthetic apatite CaP bone substitutes, fillers and cements have 
excellent biocompatibility and have been the focus of considerable applications in 
the dental and orthopedic fields since early 1980s (Jarcho, 1981; Brown and Chow, 
1985; Hollinger and Battistone, 1986; Hollinger et al., 1996; Driessens et al., 1995).  
Previously, CaP bone substitutes have a tendency to be developed either by HA or β-
TCP. Although HA and β-TCP were found to be useful as bone fillers, they have 
specific weakness. Crystalline forms of HA undergo osseointegration but resorption 
rates have been relatively slow compared to rates of new bone formation (Klein et al., 
1983; Whittaker et al., 1989; Frayssinet et al., 1993). The β-TCP tends to be more 
resorbable than HA, but its resorption rates are still unsatisfactory and somewhat 
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unpredictable (Mors and Kaminski, 1975; Metsger et al., 1982; Hollinger and 
Battistone, 1986). Besides that, the most common CPCs yield a poorly crystalline, 
precipitated HA similar in structure to natural bone mineral. There is a number of 
CPCs currently commercially available. However, due to limited compressive 
strength, they are limited to non-stress-bearing applications, including maxillofacial 
surgery, repair of cranial defects and dental fillings (Rafal et al., 2002). Table 2.1 and 
Table 2.2 give common types of CaPs and the main features of most common CPCs 
for bone substitute materials respectively. Table 2.3 lists the properties of 3 common 
formulations of CPCs. In short, the advantages of CPCs include being injectable, 
moldable, bone defects, to exhibit excellent biocompatibility and to be 
osteoconductors.  
 
Table 2.1: Characteristic of common type of CaPs (Evalina and Vikas, 2008). 
 
Calcium Phosphates (CaPs) Characteristic 
Dicalcium phosphate Present in renal calculi and fracture callus, 
a synthetic source of calcium and 
phosphate 
Dicalcium phosphate dehydrate 
(DCPD) 
Contains brushite, hydrated CaP, a 
common and widely used animal 
supplement 
Octocalcium phosphate Precursor for HA in teeth, bioactive and 
biodegradable grafting material 
Amorphous calcium phosphate 
(ACP) 
TCP, substance used as a dental treatment 
Precipitated HA TCP, a naturally occurring mineral form 
of calcium apatite, commonly used as a 
filler to replace amputated bone or as a 
coating to promote bone ingrowth into 
prosthetic implants 
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Table 2.2: Main features of most common CPCs for bone substitute materials 
(Becker and Ogon, 2008; Gladius, 2005). 
 
Features Calcium phosphate cements (CPCs) 
Hydrophilicity Hydrophilic 
Injectability Critical 
Setting time < 20 minutes 
Setting rate Slow 
Temperature change Negligible 
Tensile strength < 15 MPa 
Compressive strength < 100 MPa 
Porosity 40 - 60 % 
Pore diameter 0.1 – 10 μm 
Resorption Little to great 
Bone-cement contact Excellent 
Radiopacity Very high 
Toxicity No 
Resorption rate Neither too high nor too low 
Osteoconductivity Excellent 
Osteoinductivity Excellent 
Biocompatibility Excellent 
Bioactivity Excellent 
Cost Low 
 
Table 2.3: Properties of CPCs (Schmit, 1999). 
 
Formulation Bone Source Α-BSM Embarc Norian SRS/CRS 
Components Tetracalcium 
phosphate (TTCP), 
Ca4(PO4)2O and 
dicalcium 
phosphate 
dihydrate (DCPD), 
Ca(HPO4).H2O 
Decarbonated ACP 
and either DCPD, 
calcium 
metaphosphate, 
calcium 
heptaphosphate, 
calcium 
pyrophosphate, or 
TCP 
Monocalcium 
phosphate,  
β-TCP, calcium 
carbonate 
Compressive 
strength 
36 MPa (for first 24 
hours) 
Unknown 
 
55 MPa 
Resorbable Minimally Yes Completely 
Commercially 
available 
Yes Yes Yes 
Pore diameter 2-5 nm Unknown 300 Å 
Initial setting 
time 
10-15 min 15-20 min 10 min 
Final setting 
time 
4 hours 1 hour 12 hours 
Osteoconductive Yes Yes Yes 
Sets in presence 
of fluid 
No (must be kept 
dry) 
Yes Yes 
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The most generally used injectable bone cement is PMMA, but it suffers from 
the fact that it does not degrade and its high curing temperatures can cause necrosis 
of the surrounding tissue (Peter et al., 1997). Therefore, further development of 
alternative injectable materials is necessary. CPC is an attractive candidate because 
of it self-hardens to form HA, excellent osteoconductivity and bone-replacement 
ability (Brown and Chow, 1986; Chohayeb et al., 1987; Chow and Takagi, 1989; 
Fukase et al., 1990; Chow, 1991; Costantino, 1991; Friedman et al., 1991; Sugawara 
et al., 1992; Ishikawa et al., 1994; Ishikawa and Asoaka, 1995; Ginebra et al., 1997; 
Constantz et al., 1998; Miyamoto et al., 1999) and have promising for use in 
craniofacial and orthopedic repair (Driessens et al., 1993; Peter et al., 1997; Chow et 
al., 1998; Becker and Ogon, 2008; Evalina and Vikas, 2008). 
 
The development of i-CPC formulations has good prospects for minimally 
invasive surgical techniques developed in recent years. Since then, CPCs have 
attracted much attention and different formulations have been proposed (LeGeros et 
al., 1982; Driessens et al., 1994; Constantz et al., 1995; Ginebra et al., 1997; Freche 
et al., 1999; Tofighi et al., 2000). The development of self-setting CPCs has 
extended the application of CaP to IBS that can be shaped and molded to fit irregular 
defects, with osseointegrative properties comparable to or better than bulk CaP 
(Brown and Chow, 1985). Compared with non-setting IBS, CPCs showed excellent 
mechanical properties and do not involve potentially toxic reagents or strongly 
exothermic setting reactions (Brown and Chow, 1985; Fernandez et al., 1996; Liu et 
al., 1997; Fernandez et al., 1998; Boudeville et al., 1999; De Maeyer et al., 2000; 
Yuasa et al., 2001). CPCs are a rising class of bone substitute materials that can be 
identified as excellent alloplastic materials for osseous augmentation due to the 
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reason of the unique combination of osteoconductivity, biocompatibility and 
mouldability. CPCs can be molded and shaped to fill intricate bony cavities or 
narrow dental defect sites. In this context, CPCs are more attractive than HA ceramic 
granules. In addition, CPCs are more suitable than PMMA bone cements due to the 
non-toxic, non-carcinogenic, non-exothermic setting and negligible shrinkage 
properties of CPCs. They show excellent in vivo resorption (Manoj and Varma, 
2003). 
 
In contrast to PMMA-based cement (Leeson and Lippett, 1993), the setting 
reaction of CPC occurs with minimal exothermic at a physiological pH value without 
the release of monomer. Several apatite cements are accepted for repair of cranial 
defects in humans (Friedman et al., 1998; Sarkar et al., 2001; Kopylov et al., 2002). 
However, the use of apatite cements is limited to non-load-bearing or low-load-
bearing applications due to their poor mechanical performance relative to bone 
(Reilly and Burstein, 1975). Kingery (1950) was the first to report the formation of 
CPCs as part of a larger study of metal ion phosphate cements. He proposed that 
acid-base systems produce the strongest cements when the rate of reaction is slow. 
This rule is commonly used to modify CPCs, especially cements forming brushite 
that proceed through a fairly vigorous reaction between a basic CaP and phosphoric 
acid. In addition to adjust the rate of reaction, some additives are used to modify the 
rheology of the paste or to act as porogens. CPC has been broadly considered 
because of its attractive characters as self-setting, good biocompatibility and being 
readily molding. Basically, i-CPC has been developed for non invasive surgery 
(Manoj and Varma, 2003). The most important character of i-CPC is plasticity. 
Moreover by changing the associated parameters for example the injectable time and 
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porosity, the strength and degradation speed can be adjusted for the different clinical 
applications. Also, it can be an excellent carrier for the growth factor, medicine or 
gene through the simple physical mixture (Li et al., 2007). 
 
Different studies on CPCs have shown that they are highly biocompatible and 
osteoconductive materials, with potential use in tissue regeneration (Jansen et al., 
1995; Kurashina et al., 1997; Friedman et al., 1998; Yuan et al., 2000; Torner, 2001; 
Larsson and Bauer, 2002; Ooms et al., 2003). One of the most important 
characteristics of CPCs is that they are supposed to be osteotransductive. Thus, they 
could be resorbed slowly and transformed simultaneously into new bone tissue, when 
placed in a bony environment (Yuan et al., 2000). The CPC paste can thoroughly 
adapt to neighboring bone even with irregular shaped cavities and then harden in situ 
to form HA. Since the HA from CPC is formed in an aqueous environment at 37°C, 
it is more similar to biological apatite than sintered HA formed at higher 
temperatures. Additionally, the benefit of low temperature formation could allow 
organic molecules and even living cells to be incorporated into the cement (Yuan et 
al., 2000). Thus, CPC are highly promising for large clinical uses due to their self-
setting ability, highly bioactivity, bioresorbability, excellent osteoconductivity and 
capability to be replaced by new bone (Costantino et al., 1992; Friedman et al., 1998; 
Chow, 2000). Besides, CPC was approved in 1996 by the Food and Drug 
Administration for repairing craniofacial defects in humans (Friedman et al., 1998). 
On the other hand, the low strength and susceptibility to catastrophic fracture have 
limited CPC to only non load-bearing repairs (Friedman et al., 1998; Costantino et 
al., 1992; Chow, 2000).  
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To facilitate bony ingrowth and implant fixation, macropores are needed 
(Hing et al., 1999; Pilliar et al., 2001; Livingston et al., 2002; Gan and Pilliar, 2004). 
Macroporous CPC can be produced in situ by using a foaming agent such as 
hydrogen peroxide solution (Almirall et al., 2004), a hydrophobic liquid or oil 
(Bohner, 2001), calcium sulfate (Fernandez et al., 2005) and degradable polymer 
microparticles (Link et al., 2006). This represents an advantage of CPC over sintered 
HA but macroporous severely degrade the CPC strength (Xu et al., 2001). A study 
showed that the strength only increases once new bone starts to grow into the 
macroporous (Martin et al., 1989; Shors and Holmes, 1993). 
 
In order to achieve a controlled combination of degradation behavior and 
bioactivity in order to promote bone formation, β-TCP and DCPA were used as the 
main components of the CPC material (Kitamura et al., 2004). As a bone graft 
material, β-TCP showed excellent performance in bone formation (Epstein, 2006). 
Mixtures of β-TCP and DCPA for bone substitution have been used for many years 
(Weitao et al., 2007). The more slowly resorbing granules were surrounded by newly 
grown bone, thus providing an inverse scaffold for bone regeneration (Gisep et al., 
2003). Thus, by adding of β-TCP granules, the overall resorption rate of the cement 
can be tailored to specific needs and the bone formation rate can be controlled. 
Cements containing β-TCP and DCPA have been found to degrade completely in 
vivo after 16 weeks (Weitao et al., 2007). 
 
2.1.2     Injectability of Calcium Phosphate Cements (CPCs) 
One of the drawbacks of CPCs is their poor ability to be injected through a 
thin long cannula attached to a syringe, such as in minimally invasive clinical 
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applications (Leroux et al., 1999; Khairoun et al., 1998; Bohner and Baroud, 2005). 
In most research works, injectability has been related to the viscosity of the CPC 
(Leroux et al., 1999; Khairoun et al., 1998; Ratier et al., 2004; Bohner and Baroud, 
2005; Wang et al., 2006). Full injectability could not be reached even when no 
cannula was used. This implies that filter pressing occurred even for very small 
forces. Consequently, a solution might be obtained by reducing the ability of the 
mixing liquid to pass through the powder. Thus, injectability of cement could be 
improved by increasing the viscosity of the mixing liquid or reducing the 
permeability of the powder (Otsuka et al., 1995; Leroux et al., 1999; Khairoun et al., 
1998; Ratier et al., 2004; Bohner and Baroud, 2005; Wang et al., 2006; Habib et al., 
2008). 
 
Several approaches can be used to improve and manipulate the CPC 
injectability such as changes of particle size (Bohner and Baroud, 2005), particle 
shape (Ishikawa, 2003), mixing liquid viscosity (Khairoun et al., 1998; Bohner and 
Baroud, 2005), L/P ratio (Livingston et al., 2002), paste rheology and additives 
(Gbureck et al., 2004).  Any change in L/P ratio can influence the basic properties of 
CPC such as setting time, injectability, porosity, compressive strength and 
resorbability. For example, a low L/P ratio decreases the porosity and increases 
compressive strength (Hesaraki et al., 2007) while high L/P ratios improve the 
injectability of the cement paste, but this may cause a prolonged setting time and 
decrease the mechanical property of the cement because a high L/P ratio can produce 
a fluid with low viscosity paste through dilution (Bohner and Baroud, 2005; Hugo et 
al., 2008; Qi et al., 2008). Besides that, the experimental and theoretical approach 
predicted that the injectability of the cement paste could be improved by increasing 
